<bill session="116" type="hr" number="606" updated="2022-11-01T13:49:46Z">
  <state datetime="2019-09-27">REFERRED</state>
  <status>
    <introduced datetime="2019-09-27"/>
  </status>
  <introduced datetime="2019-09-27"/>
  <titles>
    <title type="display">Calling for sickle cell trait research, surveillance, and public education and awareness, and for other purposes.</title>
    <title type="official" as="introduced">Calling for sickle cell trait research, surveillance, and public education and awareness, and for other purposes.</title>
  </titles>
  <sponsor bioguide_id="L000551"/>
  <cosponsors>
    <cosponsor bioguide_id="B001270" joined="2020-05-08"/>
    <cosponsor bioguide_id="B001257" joined="2020-06-08"/>
    <cosponsor bioguide_id="B001304" joined="2019-09-27"/>
    <cosponsor bioguide_id="B001248" joined="2019-09-27"/>
    <cosponsor bioguide_id="C001068" joined="2019-09-27"/>
    <cosponsor bioguide_id="D000096" joined="2019-09-27"/>
    <cosponsor bioguide_id="D000624" joined="2019-10-15"/>
    <cosponsor bioguide_id="F000455" joined="2019-09-27"/>
    <cosponsor bioguide_id="J000032" joined="2019-09-27"/>
    <cosponsor bioguide_id="J000126" joined="2020-05-08"/>
    <cosponsor bioguide_id="J000288" joined="2020-05-08"/>
    <cosponsor bioguide_id="N000147" joined="2019-09-27"/>
    <cosponsor bioguide_id="O000172" joined="2019-10-15"/>
    <cosponsor bioguide_id="P000617" joined="2019-10-15"/>
    <cosponsor bioguide_id="S001157" joined="2019-09-27"/>
    <cosponsor bioguide_id="S000248" joined="2019-09-27"/>
    <cosponsor bioguide_id="S001185" joined="2019-09-27"/>
    <cosponsor bioguide_id="T000481" joined="2019-09-27"/>
  </cosponsors>
  <actions>
    <action datetime="2019-09-27">
      <text>Introduced in House</text>
    </action>
    <action datetime="2019-09-27">
      <text>Sponsor introductory remarks on measure.</text>
      <reference ref="CR H8060"/>
    </action>
    <action datetime="2019-09-27" state="REFERRED">
      <text>Referred to the House Committee on Energy and Commerce.</text>
    </action>
    <action datetime="2019-09-30">
      <text>Referred to the Subcommittee on Health.</text>
    </action>
  </actions>
  <committees>
    <committee code="HSIF" name="House Energy and Commerce" subcommittee="" activity="Referral"/>
    <committee code="HSIF14" name="House Energy and Commerce" subcommittee="Health" activity="Referral"/>
  </committees>
  <relatedbills/>
  <subjects>
    <term name="Health"/>
    <term name="Blood and blood diseases"/>
    <term name="Health care coverage and access"/>
    <term name="Health promotion and preventive care"/>
    <term name="Hereditary and development disorders"/>
    <term name="Medical research"/>
    <term name="Medical tests and diagnostic methods"/>
    <term name="Minority health"/>
  </subjects>
  <amendments/>
  <summary date="2021-02-10T16:42:05Z" status="Introduced in House">This resolution recognizes the challenges in addressing health outcomes among people with sickle cell trait and sickle cell disease. (Sickle cell disease refers to blood disorders resulting from abnormal red blood cells.) The resolution also (1) encourages the medical community to make individuals aware of their sickle cell trait status, (2) urges the Department of Health and Human Services to develop a public awareness campaign regarding the importance of individuals knowing their sickle-cell trait status and to expand access for screening and counseling, and (3) commits to ensuring equitable access to new treatments and supporting research on sickle cell trait and sickle cell disease.</summary>
</bill>
